Oregon Health & Science University 8th Annual MS and CNS Neuroimmunology Symposium 2025

Advanced Updates in Multiple Sclerosis & Neuroimmunologic Disorders

The Oregon Health & Science University (OHSU) 8th Annual MS and CNS Neuroimmunology Symposium 2025 is an accredited virtual symposium focused on the diagnosis, treatment, and evolving management of neuroimmunologic disorders affecting the central and peripheral nervous systems.

This specialized half-day program delivers practical, evidence-based updates in:

• Multiple sclerosis (MS)
• Myasthenia gravis
• Chronic inflammatory demyelinating polyneuropathy (CIDP)
• Transverse myelitis
• Neuroimmune fatigue management
• Anti-amyloid therapies in Alzheimer’s disease

through expert-led lectures and case-based clinical discussions designed to improve patient care and multidisciplinary neurological practice.

The symposium emphasizes current diagnostic criteria, emerging therapeutics, disease-modifying treatment strategies, and practical clinical decision-making in neuroimmunology.

📦 Product Details

• 🎥 6 Video Lectures
• 🎧 6 Audio Files
• 📝 6 Subtitle Files (.vtt)
• 📄 1 PDF
• 💾 Total Size: 2 GB
• 📅 Date: October 11, 2025
• 🕒 Time: 8:30 a.m. – 12:30 p.m.
• 🌐 Format: Virtual Symposium
• 🧠 Specialty: Neuroimmunology & Multiple Sclerosis

👨‍⚕️ Target Audience

This symposium is ideal for:

• Neurologists
• Neuroimmunologists
• Rheumatologists
• Ophthalmologists
• Neurosurgeons
• Internal medicine physicians
• Nurse practitioners
• Rehabilitation specialists
• Physical and occupational therapists
• Neuroscience researchers

It is especially valuable for clinicians seeking:
✔️ Multiple sclerosis treatment updates
✔️ Neuroimmunology management strategies
✔️ CIDP and myasthenia gravis education
✔️ Neurodegenerative disease therapy updates
✔️ Evidence-based fatigue management approaches

🧠 Program Overview

Neuroimmunologic diseases continue to evolve rapidly with advances in:

• Immunotherapy
• Disease-modifying treatments
• Biomarker development
• Neurodegenerative therapeutics
• Diagnostic criteria refinement

This symposium provides focused clinical updates designed to help healthcare professionals:
✔️ Improve diagnostic accuracy
✔️ Optimize treatment strategies
✔️ Apply evidence-based neuroimmunology care
✔️ Recognize evolving therapeutic paradigms
✔️ Enhance multidisciplinary patient management

The curriculum integrates current research findings with practical bedside application.

🎯 Learning Objectives

After completing this symposium, participants will be able to:

✔️ Identify current diagnostic criteria and treatment updates for myasthenia gravis
✔️ Apply updated management strategies for CIDP
✔️ Evaluate when and how to discontinue disease-modifying therapies in MS patients
✔️ Improve diagnostic accuracy in transverse myelitis through case-based analysis
✔️ Implement evidence-based fatigue management strategies in MS
✔️ Assess eligibility and monitoring requirements for anti-amyloid therapies in Alzheimer’s disease

🧩 Core Topics Covered

🧠 Multiple Sclerosis (MS)

• Disease-modifying therapy management
• Criteria for stopping therapy
• Long-term MS treatment strategies
• Fatigue management in MS

⚡ Myasthenia Gravis

• Updated diagnostic criteria
• Emerging treatment approaches
• Clinical management pearls

🔬 Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

• Clinical recognition
• Diagnostic workup
• Modern immunotherapy strategies
• Longitudinal disease management

🧬 Transverse Myelitis

• Case-based diagnostic approaches
• Differential diagnosis
• Acute and chronic treatment strategies

🧓 Anti-Amyloid Therapies

• Alzheimer’s disease therapeutics
• Patient selection criteria
• Monitoring and safety considerations
• Early-stage cognitive disease management

🌙 Fatigue in Neuroimmunologic Disease

• Evidence-based fatigue interventions
• Symptom management strategies
• Quality-of-life optimization

📚 Educational Features

✔️ Accredited Virtual Symposium

Focused, high-yield neuroimmunology education in a concise format.

✔️ Case-Based Learning

Practical clinical discussions to improve bedside decision-making.

✔️ Evidence-Based Updates

Current treatment guidelines and therapeutic innovations.

✔️ Multidisciplinary Neuroimmunology Focus

Integrates neurology, rehabilitation, rheumatology, and neuroscience care.

✔️ Flexible Learning Materials

Includes videos, audio recordings, subtitles, and downloadable PDF resources.

⭐ Why This Symposium Stands Out

✔️ Focused Neuroimmunology Education

Comprehensive updates on MS, CIDP, myasthenia gravis, and transverse myelitis.

✔️ Practical Clinical Emphasis

Designed for immediate integration into patient care.

✔️ Modern Therapeutic Coverage

Includes disease-modifying therapies and anti-amyloid treatments.

✔️ Strong Case-Based Format

Improves clinical reasoning and diagnostic accuracy.

✔️ Multidisciplinary Perspective

Relevant for neurologists, rehabilitation teams, and neuroimmune specialists.

🚀 Clinical Value

The OHSU 8th Annual MS and CNS Neuroimmunology Symposium 2025 provides a concise yet highly practical review of modern neuroimmunologic disease management.

By integrating:

• Multiple sclerosis care
• Myasthenia gravis updates
• CIDP management
• Transverse myelitis diagnosis
• Neuroimmune fatigue treatment
• Anti-amyloid therapies for Alzheimer’s disease

the symposium equips clinicians with evidence-based tools for improving outcomes in complex neurologic and neuroimmunologic disorders.

For neurologists, neuroimmunologists, rheumatologists, and multidisciplinary neuroscience professionals seeking focused neuroimmune education in 2025, this OHSU symposium represents a valuable clinical resource.

+ Topics:

• 01 Neuromuscular Part I Myasthenia Gravis – Updates
• 02 Neuromuscular Part II Chronic Inflammatory Demyelinating Polyneuropathy – Updates
• 03 When to stop therapy, discontinuing DMT in MS
• 04 Transverse myelitis, a case-based discussion
• 05 Managing Fatigue in MS
• 06 Anti-Amyloid Therapies for the Treatment of Early-Stage Alzheimer’s disease